Deep Brain Stimulation Devices Market Analysis and Forecast to 2031: By Product (Single Channel, Dual Channel), Application (Depression, Dystonia, Parkinson’s Disease, Others), End-User (Hospitals, Ambulatory Surgical Centers, Neurological Clinics, Others), and Region

Deep brain stimulation (DBS) is a surgical procedure used to treat a variety of movement disorders, including Parkinson’s disease, essential tremor, and dystonia. DBS involves implanting a small device called a stimulator in the brain. The stimulator sends electrical impulses to specific areas of the brain, which can help to reduce or eliminate symptoms.

DBS is usually performed as a two-stage procedure. In the first stage, a surgeon makes a small opening in the skull and inserts a thin, flexible wire called a lead into the brain. The lead is then connected to the stimulator, which is implanted under the skin in the chest. In the second stage, the surgeon adjusts the settings on the stimulator to achieve the desired effect.

DBS is generally safe and effective, but like any surgery, there are risks involved. The most common side effects of DBS include headache, dizziness, and nausea. More serious side effects, such as stroke or seizures, are rare.

Key Trends

There are several key trends in Deep Brain Stimulation Devices technology.

First, there is a trend toward miniaturization of the devices. This is important because it allows for less invasive procedures and shorter recovery times.

Second, there is a trend toward more targeted stimulation. This means that the devices are able to more precisely target specific areas of the brain that need to be stimulated.

Third, there is a trend toward longer-term stimulation. This means that the devices are able to provide stimulation for a longer period of time, which is important for patients who need long-term treatment.

Key Drivers

Deep brain stimulation (DBS) is a surgical procedure in which electrodes are implanted into specific areas of the brain. These electrodes deliver electrical impulses to specific areas of the brain that control movement.

DBS is used to treat a number of different conditions, including Parkinson’s disease, essential tremor, and dystonia. It is also being investigated as a treatment for other conditions such as Alzheimer’s disease, depression, and obsessive-compulsive disorder.

The key drivers of the deep brain stimulation devices market are the increasing prevalence of neurological disorders, the growing number of clinical trials for deep brain stimulation, and the increasing adoption of deep brain stimulation.

The key drivers of the deep brain stimulation devices market are the increasing prevalence of neurological disorders, the growing number of clinical trials for deep brain stimulation, and the increasing adoption of deep brain stimulation.

Restraints & Challenges

One of the key restraints for the growth of the global deep brain stimulation devices market is the lack of awareness about the availability of these devices and their potential benefits. In addition, the high cost of these devices is another key restraint for the market growth.

There are some challenges associated with the use of deep brain stimulation devices, such as the risk of infection, bleeding, and stroke. In addition, the long-term effects of these devices are not yet known, which is a key challenge for the market growth.

Market Segments

The deep brain stimulation devices market report is bifurcated on the basis of product, application, end-user, and region. On the basis of technology, it is segmented into single channel and dual channel. Based on application, it is analyzed across depression, dystonia, Parkinson’s disease, and others. By end-user, it is categorized into hospitals, ambulatory surgical centers, neurological clinics, and others. Region-wise, it is studied across North America, Europe, Asia-Pacific, and rest of the World.

Key Players

The deep brain stimulation devices market report includes players such as Abbott, Medtronic, Boston Scientific Corp, Aleva Neurotherapeutics S.A., Nexstim, LivaNova PLC, Neuropace Inc., Nevro Corporation, NeuroSigma, Inc., and Cyberonics, Inc.

Why GIS?

Table of Contents

Chapter 1. Market Introduction
1.1. Objectives of the Study
1.2. Market Definition and Research & Scope
1.3. Research Methodologies
1.4. Market Estimation Techniques

Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of the Market

Chapter 3. Deep Brain Stimulation Devices Market Outlook
3.1. Deep Brain Stimulation Devices Market Segmentation
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.1.3. Driver 3
3.2.2. Market Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.3. Porter’s Five Forces Analysis
3.3.1. Threat of New Entrants
3.3.2. Threat of Substitutes
3.3.3. Bargaining Power of Buyers
3.3.4. Bargaining Power of Supplier
3.3.5. Competitive Rivalry
3.4. PESTLE Analysis
3.5. Value Chain Analysis
3.5.1. Raw Material Suppliers
3.5.2. Manufacturers
3.5.3. Wholesalers and/or Retailers
3.6. Impact of the Russia and Ukraine War on the Global Deep Brain Stimulation Devices Market

Chapter 4. Economic Impact of COVID-19
4.1. Overall Impact of COVID-19
4.2. Impact of COVID On the Global Deep Brain Stimulation Devices Market
4.3. Economic Impact Analysis

Chapter 5. Deep Brain Stimulation Devices Market by Product
5.1. Market Overview
5.2. Single Channel
5.2.1. Market Size and Forecast, 2021-2031 ($Million)
5.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
5.3. Dual Channel
5.3.1. Market Size and Forecast, 2021-2031 ($Million)
5.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 6. Deep Brain Stimulation Devices Market by Application
6.1. Market Overview
6.2. Depression
6.2.1. Market Size and Forecast, 2021-2031 ($Million)
6.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.3. Dystonia
6.3.1. Market Size and Forecast, 2021-2031 ($Million)
6.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.4. Parkinson’s Disease
6.4.1. Market Size and Forecast, 2021-2031 ($Million)
6.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.5. Others
6.5.1. Market Size and Forecast, 2021-2031 ($Million)
6.5.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 7. Deep Brain Stimulation Devices Market by End-User
7.1. Market Overview
7.2. Hospitals
7.2.1. Market Size and Forecast, 2021-2031 ($Million)
7.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
7.3. Ambulatory Surgical Centers
7.3.1. Market Size and Forecast, 2021-2031 ($Million)
7.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
7.4. Neurological Clinics
7.4.1. Market Size and Forecast, 2021-2031 ($Million)
7.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
7.5. Others
7.5.1. Market Size and Forecast, 2021-2031 ($Million)
7.5.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 8. Deep Brain Stimulation Devices Market, by Region
8.1. Overview
8.2. North America
8.2.1. Key Market Trends and Opportunities
8.2.2. North America Deep Brain Stimulation Devices Market Size and Forecast by Product, 2021-2031, ($Million)
8.2.3. North America Deep Brain Stimulation Devices Market Size and Forecast by Application, 2021-2031, ($Million)
8.2.4. North America Deep Brain Stimulation Devices Market Size and Forecast by End-User, 2021-2031, ($Million)
8.2.5. North America Deep Brain Stimulation Devices Market Size and Forecast by Country, 2021-2031, ($Million)
8.2.6. The U.S.
8.2.6.1. The U.S. Deep Brain Stimulation Devices Market Size and Forecast by Product, 2021-2031, ($Million)
8.2.6.2. The U.S. Deep Brain Stimulation Devices Market Size and Forecast by Application, 2021-2031, ($Million)
8.2.6.3. The U.S. Deep Brain Stimulation Devices Market Size and Forecast by End-User, 2021-2031, ($Million)
8.2.7. Canada
8.2.7.1. Canada Deep Brain Stimulation Devices Market Size and Forecast by Product, 2021-2031, ($Million)
8.2.7.2. Canada Deep Brain Stimulation Devices Market Size and Forecast by Application, 2021-2031, ($Million)
8.2.7.3. Canada Deep Brain Stimulation Devices Market Size and Forecast by End-User, 2021-2031, ($Million)
8.2.8. Mexico
8.2.8.1. Mexico Deep Brain Stimulation Devices Market Size and Forecast by Product, 2021-2031, ($Million)
8.2.8.2. Mexico Deep Brain Stimulation Devices Market Size and Forecast by Application, 2021-2031, ($Million)
8.2.8.3. Mexico Deep Brain Stimulation Devices Market Size and Forecast by End-User, 2021-2031, ($Million)
8.3. Europe
8.3.1. Key Market Trends and Opportunities
8.3.2. Europe Deep Brain Stimulation Devices Market Size and Forecast by Product, 2021-2031, ($Million)
8.3.3. Europe Deep Brain Stimulation Devices Market Size and Forecast by Application, 2021-2031, ($Million)
8.3.4. Europe Deep Brain Stimulation Devices Market Size and Forecast by End-User, 2021-2031, ($Million)
8.3.5. Europe Deep Brain Stimulation Devices Market Size and Forecast by Country, 2021-2031, ($Million)
8.3.6. Germany
8.3.6.1. Germany Deep Brain Stimulation Devices Market Size and Forecast by Product, 2021-2031, ($Million)
8.3.6.2. Germany Deep Brain Stimulation Devices Market Size and Forecast by Application, 2021-2031, ($Million)
8.3.6.3. Germany Deep Brain Stimulation Devices Market Size and Forecast by End-User, 2021-2031, ($Million)
8.3.7. France
8.3.7.1. France Deep Brain Stimulation Devices Market Size and Forecast by Product, 2021-2031, ($Million)
8.3.7.2. France Deep Brain Stimulation Devices Market Size and Forecast by Application, 2021-2031, ($Million)
8.3.7.3. France Deep Brain Stimulation Devices Market Size and Forecast by End-User, 2021-2031, ($Million)
8.3.8. U.K.
8.3.8.1. U.K. Deep Brain Stimulation Devices Market Size and Forecast by Product, 2021-2031, ($Million)
8.3.8.2. U.K. Deep Brain Stimulation Devices Market Size and Forecast by Application, 2021-2031, ($Million)
8.3.8.3. U.K. Deep Brain Stimulation Devices Market Size and Forecast by End-User, 2021-2031, ($Million)
8.3.9. Spain
8.3.9.1. Spain Deep Brain Stimulation Devices Market Size and Forecast by Product, 2021-2031, ($Million)
8.3.9.2. Spain Deep Brain Stimulation Devices Market Size and Forecast by Application, 2021-2031, ($Million)
8.3.9.3. Spain Deep Brain Stimulation Devices Market Size and Forecast by End-User, 2021-2031, ($Million)
8.3.10. Italy
8.3.10.1. Italy Deep Brain Stimulation Devices Market Size and Forecast by Product, 2021-2031, ($Million)
8.3.10.2. Italy Deep Brain Stimulation Devices Market Size and Forecast by Application, 2021-2031, ($Million)
8.3.10.3. Italy Deep Brain Stimulation Devices Market Size and Forecast by End-User, 2021-2031, ($Million)
8.3.11. Rest of Europe
8.3.11.1. Rest of Europe Deep Brain Stimulation Devices Market Size and Forecast by Product, 2021-2031, ($Million)
8.3.11.2. Rest of Europe Deep Brain Stimulation Devices Market Size and Forecast by Application, 2021-2031, ($Million)
8.3.11.3. Rest of Europe Deep Brain Stimulation Devices Market Size and Forecast by End-User, 2021-2031, ($Million)
8.4. Asia-Pacific
8.4.1. Key Market Trends and Opportunities
8.4.2. Asia-Pacific Deep Brain Stimulation Devices Market Size and Forecast by Country, 2021-2031, ($Million)
8.4.3. Asia-Pacific Deep Brain Stimulation Devices Market Size and Forecast by Product, 2021-2031, ($Million)
8.4.4. Asia-Pacific Deep Brain Stimulation Devices Market Size and Forecast by Application, 2021-2031, ($Million)
8.4.5. Asia-Pacific Deep Brain Stimulation Devices Market Size and Forecast by End-User, 2021-2031, ($Million)
8.4.6. China
8.4.6.1. China Deep Brain Stimulation Devices Market Size and Forecast by Product, 2021-2031, ($Million)
8.4.6.2. China Deep Brain Stimulation Devices Market Size and Forecast by Product Application, 2021-2031, ($Million)
8.4.6.3. China Deep Brain Stimulation Devices Market Size and Forecast by End-User, 2021-2031, ($Million)
8.4.7. India
8.4.7.1. India Deep Brain Stimulation Devices Market Size and Forecast by Product, 2021-2031, ($Million)
8.4.7.2. India Deep Brain Stimulation Devices Market Size and Forecast by Application, 2021-2031, ($Million)
8.4.7.3. India Deep Brain Stimulation Devices Market Size and Forecast by End-User, 2021-2031, ($Million)
8.4.8. Japan
8.4.8.1. Japan Deep Brain Stimulation Devices Market Size and Forecast by Product, 2021-2031, ($Million)
8.4.8.2. Japan Deep Brain Stimulation Devices Market Size and Forecast by Application, 2021-2031, ($Million)
8.4.8.3. Japan Deep Brain Stimulation Devices Market Size and Forecast by End-User, 2021-2031, ($Million)
8.4.9. South Korea
8.4.9.1. South Korea Deep Brain Stimulation Devices Market Size and Forecast by Product, 2021-2031, ($Million)
8.4.9.2. South Korea Deep Brain Stimulation Devices Market Size and Forecast by Application, 2021-2031, ($Million)
8.4.9.3. South Korea Deep Brain Stimulation Devices Market Size and Forecast by End-User, 2021-2031, ($Million)
8.4.10. Rest of APAC
8.4.10.1. Rest of APAC Deep Brain Stimulation Devices Market Size and Forecast by Product, 2021-2031, ($Million)
8.4.10.2. Rest of APAC Deep Brain Stimulation Devices Market Size and Forecast by Application, 2021-2031, ($Million)
8.4.10.3. Rest of APAC Deep Brain Stimulation Devices Market Size and Forecast by End-User, 2021-2031, ($Million)
8.5. Rest of the World
8.5.1. Key Market Trends and Opportunities
8.5.2. Rest of the World Deep Brain Stimulation Devices Market Size and Forecast by Product, 2021-2031, ($Million)
8.5.3. Rest of the World Deep Brain Stimulation Devices Market Size and Forecast by Application, 2021-2031, ($Million)
8.5.4. Rest of the World Deep Brain Stimulation Devices Market Size and Forecast by End-User, 2021-2031, ($Million)
8.5.5. Rest of the World Deep Brain Stimulation Devices Market Size and Forecast by Country, 2021-2031, ($Million)
8.5.6. Latin America
8.5.6.1. Latin America Deep Brain Stimulation Devices Market Size and Forecast by Product, 2021-2031, ($Million)
8.5.6.2. Latin America Deep Brain Stimulation Devices Market Size and Forecast by Application, 2021-2031, ($Million)
8.5.6.3. Latin America Deep Brain Stimulation Devices Market Size and Forecast by End-User, 2021-2031, ($Million)
8.5.7. Middle East
8.5.7.1. Middle East Deep Brain Stimulation Devices Market Size and Forecast by Product, 2021-2031, ($Million)
8.5.7.2. Middle East Deep Brain Stimulation Devices Market Size and Forecast by Application, 2021-2031, ($Million)
8.5.7.3. Middle East Deep Brain Stimulation Devices Market Size and Forecast by End-User, 2021-2031, ($Million)
8.5.8. Africa
8.5.8.1. Africa Deep Brain Stimulation Devices Market Size and Forecast by Product, 2021-2031, ($Million)
8.5.8.2. Africa Deep Brain Stimulation Devices Market Size and Forecast by Application, 2021-2031, ($Million)
8.5.8.3. Africa Deep Brain Stimulation Devices Market Size and Forecast by End-User, 2021-2031, ($Million)

Chapter 9. Competitive Landscape
9.1. Market Overview
9.2. Market Share Analysis/Key Player Positioning
9.3. Developmental Strategy Benchmarking
9.3.1. New Product Development
9.3.2. Product Launches
9.3.3. Business Expansions
9.3.4. Partnerships, Joint Ventures, and Collaborations
9.3.5. Mergers and Acquisitions

Chapter 10. Company Profiles
10.1. Abbott
10.1.1. Company Snapshot
10.1.2. Financial Performance
10.1.3. Product Offerings
10.1.4. Key Strategic Initiatives
10.1.5. SWOT Analysis
10.2. Medtronic
10.2.1. Company Snapshot
10.2.2. Financial Performance
10.2.3. Product offerings
10.2.4. Key Strategic Initiatives
10.2.5. SWOT Analysis
10.3. Boston Scientific Corp
10.3.1. Company Snapshot
10.3.2. Financial Performance
10.3.3. Product offerings
10.3.4. Key Strategic Initiatives
10.3.5. SWOT Analysis
10.4. Aleva Neurotherapeutics S.A.
10.4.1. Company Snapshot
10.4.2. Financial Performance
10.4.3. Product offerings
10.4.4. Key Strategic Initiatives
10.4.5. SWOT Analysis
10.5. Nexstim
10.5.1. Company Snapshot
10.5.2. Financial Performance
10.5.3. Product offerings
10.5.4. Key Strategic Initiatives
10.5.5. SWOT Analysis
10.6. LivaNova PLC
10.6.1. Company Snapshot
10.6.2. Financial Performance
10.6.3. Product offerings
10.6.4. Key Strategic Initiatives
10.6.5. SWOT Analysis
10.7. Neuropace Inc.
10.7.1. Company Snapshot
10.7.2. Financial Performance
10.7.3. Product offerings
10.7.4. Key Strategic Initiatives
10.7.5. SWOT Analysis
10.8. Nevro Corporation
10.8.1. Company Snapshot
10.8.2. Financial Performance
10.8.3. Product offerings
10.8.4. Key Strategic Initiatives
10.8.5. SWOT Analysis
10.9. NeuroSigma, Inc.
10.9.1. Company Snapshot
10.9.2. Financial Performance
10.9.3. Product offerings
10.9.4. Key Strategic Initiatives
10.9.5. SWOT Analysis
10.10. Cyberonics, Inc.
10.10.1. Company Snapshot
10.10.2. Financial Performance
10.10.3. Product offerings
10.10.4. Key Strategic Initiatives
10.10.5. SWOT Analysis

*The list of company is subject to change during the final compilation of the report
Key Players
  • Abbott
  • Medtronic
  • Boston Scientific Corp
  • Aleva Neurotherapeutics S.A.
  • Nexstim
  • LivaNova PLC
  • Neuropace Inc.
  • Nevro Corporation
  • NeuroSigma, Inc.
  • Cyberonics, Inc.
Market Segments

By Product 

  • Single Channel
  • Dual Channel

By Application 

  • Depression
  • Dystonia
  • Parkinson’s Disease
  • Others

By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Neurological Clinics
  • Others

By Region

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • The UK
    • Germany
    • France
    • Spain
    • Rest of Europe
  • The Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World
    • Latin America
    • The Middle East
    • Africa

Order this Report

Have questions about the scope of the report ?

Have specific requirements ?

Budget Constraints ?

Related Reports

Joint pain injections are a type of treatment…
Preimplantation Genetic Testing (PGT) is a type of…
Market Overview The global Peptide Therapeutics Market was…
The global clear aligners market was valued at…
Spatial Genomics & Transcriptomics are two branches of…
Liposuction devices are medical instruments used to remove…
Bio Decontamination is a process that involves removing,…
Ophthalmic equipment is equipment used to diagnose and…
Transrectal Ultrasound (TRUS) is a medical imaging technique…
The global HPV testing & PAP test market…